Key Insights

Highlights

Treatment Research

4 treatments under study, led by Ready To Use Supplementary Food

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Phase 2 (2)

Trial Status

Unknown2

Clinical Trials (2)

Research Network

Common Treatments

  • Ready To Use Supplementary Food1
  • Microbiota Directed Complementary Food Mdcf1
  • Ready To Use Supplementary Food Rusf1
  • Microbiota Directed Complementary Food21

Active Sponsors

  • Washington University School of Medicine2
  • International Centre for Diarrhoeal Disease Research, Bangladesh2

Top Investigators

Related Conditions

  • Microbiota2
  • Nutrition2

Activity Timeline